Search Results - "MacPhee, Iain A. M."

Refine Results
  1. 1

    Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients by Phanish, Mysore K, Hull, Richard P, Andrews, Peter A, Popoola, Joyce, Kingdon, Edward J, MacPhee, Iain A M

    Published in BMC nephrology (11-03-2020)
    “…The efficacy and safety of minimisation of immunosuppression including early steroid withdrawal in kidney transplant recipients treated with Basiliximab…”
    Get full text
    Journal Article
  2. 2
  3. 3

    CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients by SPIERINGS, N, HOLT, D. W, MACPHEE, Iain A. M

    Published in Therapeutic drug monitoring (01-06-2013)
    “…The risk of long-term chronic allograft nephropathy and graft loss after kidney transplantation is increased in patients with a high intrapatient variability…”
    Get full text
    Journal Article
  4. 4

    Tacrolimus pharmacogenetics: Polymorphisms associated with expression of cytochrome P4503A5 and P-glycoprotein correlate with dose requirement by MACPHEE, Iain A. M, FREDERICKS, Salim, TAI, Tracy, SYRRIS, Petros, CARTER, Nicholas D, JOHNSTON, Atholl, GOLDBERG, Lawrence, HOLT, David W

    Published in Transplantation (15-12-2002)
    “…There is marked heterogeneity in blood concentrations of tacrolimus following standard body-weight-based dosing. This is most apparent in black patients, who…”
    Get full text
    Journal Article
  5. 5

    A Pharmacogenetic Strategy for Immunosuppression Based on the CYP3A5 Genotype by MACPHEE, Iain A. M, HOLT, David W

    Published in Transplantation (27-01-2008)
    “…Pharmacogenetics has the potential to complement therapeutic drug monitoring in achieving target blood concentrations of the immunosuppressive drugs during the…”
    Get full text
    Journal Article
  6. 6

    Use of Pharmacogenetics to Optimize Immunosuppressive Therapy by MACPHEE, Iain A. M

    Published in Therapeutic drug monitoring (01-06-2010)
    “…Pharmacogenetic strategies offer promise as an adjunct to therapeutic drug monitoring in achieving target blood concentrations of the immunosuppressive drugs…”
    Get full text
    Conference Proceeding Journal Article
  7. 7

    Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation by BOUAMAR, Rachida, HESSELINK, Dennis A, VAN SCHAIK, Ron H. N, WEIMAR, Willem, MACPHEE, Iain A. M, DE FIJTER, Johan W, VAN GELDER, Teun

    Published in Therapeutic drug monitoring (01-04-2011)
    “…The association of CYP3A5, CYP3A4, and ABCB1 single nucleotide polymorphisms (SNPs) with cyclosporine (CsA) pharmacokinetics is controversial. The authors…”
    Get full text
    Journal Article
  8. 8

    Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements by FREDERICKS, Salim, MORETON, Michelle, REBOUX, Sandrine, CARTER, Nicholas D, GOLDBERG, Lawrence, HOLT, David W, MACPHEE, Iain A. M

    Published in Transplantation (15-09-2006)
    “…P-glycoprotein (P-gp) and the drug metabolizing enzymes have major pharmacokinetic effects. Variability in tacrolimus absorption is influenced by P-gp activity…”
    Get full text
    Journal Article
  9. 9

    Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups by Ng, Fu Liang, Holt, David W., Chang, Rene W. S., MacPhee, Iain A. M.

    Published in Nephrology, dialysis, transplantation (01-02-2010)
    “…Background. African American transplant recipients have poorer long-term outcomes than Caucasian Americans. This difference was not found in French patients,…”
    Get full text
    Journal Article
  10. 10

    Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients by Kirwan, Christopher John, Lee, Terry, Holt, David W., Grounds, R. Michael, MacPhee, Iain A. M., Philips, Barbara J.

    Published in Intensive care medicine (01-07-2009)
    “…Objective Critical illness and associated sequelae can cause severe metabolic disturbances. The effects these have on hepatic drug metabolism are poorly…”
    Get full text
    Journal Article
  11. 11

    Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial by Dixon, John J, Lane, Katie, Dalton, R Neil, Turner, Charles, Grounds, R Michael, MacPhee, Iain A M, Philips, Barbara J

    Published in Journal of translational medicine (12-02-2015)
    “…There is currently no accurate method of measuring glomerular filtration rate (GFR) during acute kidney injury (AKI). Knowledge of how much GFR varies in…”
    Get full text
    Journal Article
  12. 12

    Estimated Glomerular Filtration Rate Correlates Poorly with Four-Hour Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury by Kirwan, Christopher J., Philips, Barbara J., MacPhee, Iain A. M.

    Published in Critical Care Research and Practice (01-01-2013)
    “…Introduction. RIFLE and AKIN provide a standardised classification of acute kidney injury (AKI), but their categorical rather than continuous nature restricts…”
    Get full text
    Journal Article
  13. 13

    BK Virus Nephropathy in Renal Transplant Patients in London by WHITE, Laura H, CASIAN, Alina, HILTON, Rachel, MACPHEE, Iain A. M, MARSH, James, SWENY, Paul, TREVITT, Ray, FRANKEL, Andrew H, WARRENS, Anthony N

    Published in Transplantation (15-04-2008)
    “…BK nephropathy (BKN) is an important cause of renal transplant dysfunction, believed to be associated with higher levels of immunosuppression. We assessed the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Renohepatic crosstalk: does acute kidney injury cause liver dysfunction? by Lane, Katie, Dixon, John J, MacPhee, Iain A M, Philips, Barbara J

    Published in Nephrology, dialysis, transplantation (01-07-2013)
    “…The concept of hepatorenal syndrome is well recognized, although incompletely understood. The converse clinical problem of hepatic dysfunction in patients with…”
    Get full text
    Journal Article
  16. 16

    Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A51 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements by Fredericks, Salim, Jorga, AnaMaria, MacPhee, Iain A.M., Reboux, Sandrine, Shiferaw, Elizabeth, Moreton, Michelle, Carter, Nicholas D., Holt, David W., Johnston, Atholl

    Published in Clinical transplantation (01-03-2007)
    “…:  The intestinal efflux pump P‐glycoprotein (P‐gp), the product of the multi‐drug resistance‐1 (MDR‐1) gene, significantly influences the pharmacokinetics of…”
    Get full text
    Journal Article
  17. 17

    Pharmacogenetic biomarkers: cytochrome P450 3A5 by MacPhee, Iain A.M.

    Published in Clinica chimica acta (08-09-2012)
    “…The immunosuppressive drugs used for solid organ transplantation all have a narrow therapeutic index with wide variation between individuals in the blood…”
    Get full text
    Journal Article
  18. 18

    Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill Patients by Dixon, John J, Lane, Katie, Dalton, R Neil, Turner, Charles, MacPhee, Iain A M, Chis Ster, Irina, Philips, Barbara J

    Published in Critical care medicine (01-03-2018)
    “…OBJECTIVE:Measurement of changing glomerular filtration rate in acute kidney injury remains problematic. We have previously used a continuous infusion of…”
    Get full text
    Journal Article
  19. 19

    A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients by Boughton, Oliver, Borgulya, Gabor, Cecconi, Maurizio, Fredericks, Salim, Moreton‐Clack, Michelle, MacPhee, Iain A. M.

    Published in British journal of clinical pharmacology (01-09-2013)
    “…Aims An algorithm based on the CYP3A5 genotype to predict tacrolimus clearance to inform the optimal initial dose was derived using data from the DeKAF study…”
    Get full text
    Journal Article
  20. 20

    A renal registry for Africa: first steps by Davids, M. Razeen, Eastwood, John B., Selwood, Neville H., Arogundade, Fatiu A., Ashuntantang, Gloria, Benghanem Gharbi, Mohammed, Jarraya, Faiçal, MacPhee, Iain A.M., McCulloch, Mignon, Plange-Rhule, Jacob, Swanepoel, Charles R., Adu, Dwomoa

    Published in Clinical kidney journal (01-02-2016)
    “…There is a dearth of data on end-stage renal disease (ESRD) in Africa. Several national renal registries have been established but have not been sustainable…”
    Get full text
    Journal Article